Replies to post #18562 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

"It would appear your only argument is the share price. Look at the sector as a whole. Look at the anemic volume of the IBB and other sector specific indexes."

The IBB is 5% below its 52-week high whereas ADXS is 50% below its 52 week high so "weak biotech conditions" is no longer an excuse.